1-2 of 2
Kaitlyn Redling
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A phase 2 single-center study of carfilzomib 56 mg/m 2 with or without low-dose dexamethasone in relapsed multiple myeloma

Clinical Trials & Observations
Nikoletta Lendvai, Patrick Hilden, Sean Devlin, Heather Landau, Hani Hassoun, Alexander M. Lesokhin, Ioanna Tsakos, Kaitlyn Redling, Guenther Koehne, David J. Chung, Wendy L. Schaffer, Sergio A. Giralt
Journal: Blood
Blood (2014) 124 (6): 899–906.
https://doi.org/10.1182/blood-2014-02-556308
Published: 2014
Includes: Supplemental data
Journal Articles

Pilot Study To Evaluate The Prevalence Of Actionable Oncogenic Mutations In Patients With Relapsed Refractory Multiple Myeloma

Alexander Lesokhin, MD, Mithat Gonen, Kaitlyn Redling, Nikoletta Lendvai, MD PhD, Hani Hassoun, MD, Heather Landau, MD, David J Chung, MD PhD, Guenther Koehne, MD, PhD, Minal Patel, Kristina W. Brennan, BS, Kai Wang, MD PhD, Eric M Sanford, BS, Tim Brennan, PhD, Geoff A. Otto, PhD, Michelle K. Nahas, PhD, Doron Lipson, PhD, Philip J. Stephens, PhD, Roman Yelensky, PhD, Vincent A. Miller, MD, Marcel Van Den Brink, MD, PhD, Ross L. Levine, MD, Ahmet Dogan, MD, PhD, Sergio A Giralt, MD
Journal: Blood
Blood (2013) 122 (21): 755.
https://doi.org/10.1182/blood.V122.21.755.755
Published: 2013